Compounds, methods, compositions and kits for treating a patient with pulmonary sarcoidosis are provided. The compositions are formulated for delivery to a patient in need of treatment via inhalation. In one embodiment, the method of treating pulmonary sarcoidosis in a patient in need thereof includes administering to the lungs of the patient via inhalation, a composition comprising an effective amount of a disease-modifying antisarcoid compound, a prodrug thereof, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable inhalation excipient. The disease-modifying antisarcoid compound can be an immunomodulating agent, for example derivatives of mycophenolic acid, or a TNF-α antagonist.
本发明提供了用于治疗肺结节病患者的化合物、方法、组合物和试剂盒。所述组合物经配制后可通过吸入途径给予需要治疗的患者。在一种实施例中,治疗肺结节病的方法包括通过吸入途径向患者的肺部给予一种组合物,所述组合物包括有效量的疾病修饰性抗结节病化合物、其前药或其药学上可接受的盐和药学上可接受的吸入助剂。疾病修饰性抗结节病化合物可以是免疫调节剂,例如
麦考酚酸衍
生物或TNF-α拮抗剂。